Airing weekdays at 7:30 A.M. on

Airing weekdays at 7:30 A.M. on

Foot ulcers are common among the 30 million Americans suffering from diabetes. They’re the main cause of lower limb amputations, according to the Centers for Disease Control. With diabetes projected to rise to half a billion people worldwide, the need for improved screening and earlier intervention in diabetic foot disease is critical.

That’s why we’re learning about the importance of early intervention, and how an innovative screening device from HyperMed Imaging can potentially help patients stay one step ahead.

HyperMed Imaging, Inc. is the established leader in medical hyperspectral imaging for surface tissue oximetry. Their pioneering technology has been in service since 2006 and has been shown in published clinical research to effectively assess oxyhemoglobin, deoxyhemoglobin, and oxyhemoglobin saturation in superficial tissue for a number of key healthcare applications.

By imaging oxyhemoglobin and deoxyhemoglobin levels, as well as oxygen saturation in superficial tissue, the device provides clinicians a new understanding of perfusion, thereby leading to more informed treatment decisions. Applications include wound care, vascular care, reconstructive surgery, and limb preservation, among others. Stay tuned to learn more.

Health, Wealth, Beauty, and Business

Bringing the best tips from the experts in Atlanta in business, beauty, wealth management, child healthcare, car shopping, and more. Each year, Atlanta’s Women’s Entrepreneurship Initiative selects 15 local female entrepreneurs for a 15-month business training program. We meet women who have grown their companies, created jobs, and broke through the glass ceiling. With some […]

iMCD is the deadliest subtype of Castleman disease. Approximately one third of patients die within five years of diagnosis, and another third die within 10 years if not treated.

There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades.

Comments

comments